3 Recruiting Pheochromocytoma Phase 2 Clinical Trials

Active phase 2 studies for pheochromocytoma enrolling across the USA. Verify eligibility and contact site coordinators.

All Pheochromocytoma studies

Phase 2 Studies for Pheochromocytoma

🔵 Active, Not Recruiting Phase2

Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma

📍 Columbia University Irving Medical Center — New York, New York

View Study & Checklist ➔

🟡 Not Yet Recruiting Phase2

Zanzalintinib in Unresectable and Progressive MPGGs

📍 Brigham and Women's Hospital (BWH) — Boston, Massachusetts

View Study & Checklist ➔

🟢 Recruiting Phase2

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

📍 National Institutes of Health Clinical Center — Bethesda, Maryland

View Study & Checklist ➔